XML 17 R6.htm IDEA: XBRL DOCUMENT v3.21.2
CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)
$ in Thousands
6 Months Ended
Oct. 23, 2021
Oct. 24, 2020
Cash flows from operating activities    
Net income $ 65,624 $ 39,983
Adjustments to reconcile net income to cash provided by operating activities    
(Gain)/loss on disposal of assets (3,151) 140
Gain on sale of investments (218) (284)
Provision for doubtful accounts (944) (1,568)
Depreciation and amortization 17,785 16,351
Amortization of right-of-use lease assets 34,368 35,137
Equity-based compensation expense 6,354 6,167
Change in deferred taxes 170 1,849
Change in receivables (33,937) (28,949)
Change in inventories (59,336) (3,511)
Change in other assets (20,666) (1,926)
Change in payables 22,683 33,236
Change in lease liabilities (34,598) (32,422)
Change in other liabilities 21,300 131,507
Net cash provided by operating activities 15,434 195,710
Cash flows from investing activities    
Proceeds from disposals of assets 3,998 21
Capital expenditures (33,314) (15,442)
Purchases of investments (21,426) (17,649)
Proceeds from sales of investments 22,666 19,470
Acquisitions (4,396) (2,000)
Net cash used for investing activities (32,472) (15,600)
Cash flows from financing activities    
Payments on debt and finance lease liabilities (60) (75,013)
Holdback payments for acquisition purchases (13,500) (5,783)
Stock issued for stock and employee benefit plans, net of shares withheld for taxes (1,870) 364
Repurchases of common stock (50,640) 0
Dividends paid to shareholders (13,398) (3,216)
Dividends paid to minority interest joint venture partners [1] (1,260) (8,507)
Net cash used for financing activities (80,728) (92,155)
Effect of exchange rate changes on cash and equivalents (330) 1,944
Change in cash, cash equivalents and restricted cash (98,096) 89,899
Cash, cash equivalents and restricted cash at beginning of period 394,703 263,528
Cash, cash equivalents and restricted cash at end of period 296,607 353,427
Supplemental disclosure of non-cash investing activities    
Capital expenditures included in payables $ 7,900 $ 3,769
[1] Includes dividends paid to joint venture minority partners resulting from the repatriation of dividends from our foreign earnings that we no longer consider permanently reinvested.